ACOR
NASDAQAcorda Therapeutics Inc.
News · 26 weeks10%
2025-12-142026-06-07
Mix190d
- Leadership1(100%)
Latest news
25 items- PRFlow Sciences Appoints Michael Gesser as Chief Financial OfficerLife Sciences Finance Veteran and Flow Sciences Board Member Steps Into CFO Role to Support Company's Next Phase of GrowthRALEIGH, N.C, April 8, 2026 /PRNewswire/ -- Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Michael Gesser as its chief financial officer. Gesser, who has served as a member of the Flow Sciences board of directors since 2021, will continue serving on the board while assuming executive responsibility for all finance, accounting, tax, treasury, FP&A and investor relations functions.
- SECSEC Form 10-Q filed by Acorda Therapeutics Inc.10-Q - Acorda Therapeutics, Inc. (0001008848) (Filer)
- SECSEC Form 10-K/A filed by Acorda Therapeutics Inc. (Amendment)10-K/A - Acorda Therapeutics, Inc. (0001008848) (Filer)
- SECAcorda Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Acorda Therapeutics, Inc. (0001008848) (Filer)
- SECAcorda Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Acorda Therapeutics, Inc. (0001008848) (Filer)
- NEWSAcorda Therapeutics Reports Delisting From Nasdaq
- PRAcorda Therapeutics Announces Delisting from NasdaqAcorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company's failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company's commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders' equity of at least $10 million. Trading in the Company's common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company's common stock is quoted on the OTC Pink® Open Market platform operated by OTC Markets Group Inc. since April 12, 2024 under the "ACORQ" ticker symbol. About Acorda Therap
- NEWS12 Health Care Stocks Moving In Thursday's After-Market SessionGainers Ontrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands at $18.9 million. Ocuphire Pharma (NASDAQ:OCUP) stock rose 7.82% to $1.93. The company's market cap stands at $47.8 million. Lyell Immunopharma (NASDAQ:LYEL) stock rose 7.5% to $2.86. The market value of their outstanding shares is at $726.5 million. iSpecimen (NASDAQ:ISPC) shares rose 6.38% to $0.24. The market value of their outstanding shares is at $2.1 million. Akanda (NASDAQ:AKAN) shares moved upwards by 5.89% to $0.16. The company's market cap stands at $1.9 million. Bright Green (NASDAQ:BGXX) shares moved upwards by 5.0% to $0.25. The market val
- NEWSWhy Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents. Fastenal shares dipped 6.7% to $69.73 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Rallybio Corporation (NASDAQ:RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rent the Runway, Inc. (NA
- NEWS12 Health Care Stocks Moving In Thursday's Intraday SessionGainers Rallybio (NASDAQ:RLYB) shares moved upwards by 70.5% to $2.78 during Thursday's regular session. The company's market cap stands at $105.1 million. Eliem Therapeutics (NASDAQ:ELYM) shares rose 57.3% to $4.2. The market value of their outstanding shares is at $116.4 million. Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 40.58% to $7.17. The market value of their outstanding shares is at $210.4 million. Alpine Immune Sciences (NASDAQ:ALPN) stock moved upwards by 36.84% to $64.37. The company's market cap stands at $4.2 billion. Akanda (NASDAQ:AKAN) shares moved upwards by 29.51% to $0.15. The company's market cap stands at $1.8 million. Nektar Therapeutics (NASDAQ:NKT
- NEWS12 Health Care Stocks Moving In Thursday's Pre-Market SessionGainers Eliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday's pre-market session. The market value of their outstanding shares is at $112.2 million. Rallybio (NASDAQ:RLYB) stock increased by 49.07% to $2.43. The company's market cap stands at $91.8 million. Alpine Immune Sciences (NASDAQ:ALPN) shares rose 36.62% to $64.27. The company's market cap stands at $4.2 billion. IMAC Hldgs (NASDAQ:BACK) stock increased by 22.41% to $3.44. The market value of their outstanding shares is at $3.9 million. Healthcare Triangle (NASDAQ:HCTI) shares rose 15.3% to $1.77. The market value of their outstanding shares is at $8.2 million. Lipocine (NASDAQ:LPCN) stock ros
- NEWSWhy Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving PremarketShares of Rallybio Corporation (NASDAQ:RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rallybio shares jumped rose 77.9% to $2.90 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Rent the Runway, Inc. (NASDAQ:RENT) shares rose 40.8% to $10.42 in pre-market trading after the company reported mixed fourth-quarter financial results and issued guidance. Alpine Immune Sciences, Inc. (NASDAQ:ALPN) gained 36.1% to $64.02 in pre-market trading after Vertex entered into an agreement to acquire the company. TuanChe Limite
- NEWSWhy Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of Ascent Solar Technologies, Inc. (NASDAQ:ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Ascent Solar Technologies shares dipped 50% to $0.1374 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Marin Software Incorporated (NASDAQ:MRIN) shares jumped 152% to $0.7242 after the company announced upgrades to its integration with Microsoft Advertising. Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) gained 75% to $1.9698 after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Adial Pharmaceuticals (NASDAQ:ADIL) shares rose 61.6% to $1.83 during Wednesday's regular session. The company's market cap stands at $7.4 million. Jaguar Health (NASDAQ:JAGX) shares rose 32.22% to $0.12. The market value of their outstanding shares is at $32.8 million. Orgenesis (NASDAQ:ORGS) stock rose 27.83% to $0.62. The market value of their outstanding shares is at $21.1 million. BioSig Technologies (NASDAQ:BSGM) shares moved upwards by 15.43% to $1.87. The company's market cap stands at $17.4 million. Etao International Co (NASDAQ:ETAO) shares rose 14.65% to $4.38. The company's market cap stands at $22.4 million. Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 12.84%
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.0% to $10.16 during Tuesday's regular session. The market value of their outstanding shares is at $230.0 million. BioSig Technologies (NASDAQ:BSGM) stock increased by 27.41% to $1.58. The market value of their outstanding shares is at $14.7 million. Syros Pharmaceuticals (NASDAQ:SYRS) shares moved upwards by 24.44% to $5.6. The market value of their outstanding shares is at $148.1 million. Inspire Veterinary (NASDAQ:IVP) shares increased by 19.13% to $0.06. The company's market cap stands at $1.7 million. As per the news, the Q4 earnings report came out yesterday. Addex Therapeutics (NASDAQ:ADXN) shares moved upwards b
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers Candel Therapeutics (NASDAQ:CADL) stock increased by 27.6% to $8.17 during Friday's regular session. The company's market cap stands at $239.6 million. Galectin Therapeutics (NASDAQ:GALT) shares increased by 20.66% to $3.62. The company's market cap stands at $224.0 million. Ocugen (NASDAQ:OCGN) stock moved upwards by 17.88% to $1.78. The company's market cap stands at $456.7 million. As per the press release, Q4 earnings came out 3 days ago. Processa Pharma (NASDAQ:PCSA) shares moved upwards by 17.67% to $2.73. The market value of their outstanding shares is at $4.6 million. bioAffinity Technologies (NASDAQ:BIAF) stock rose 15.5% to $2.98. The market value of their outstanding
- NEWS12 Health Care Stocks Moving In Thursday's After-Market SessionGainers Orgenesis (NASDAQ:ORGS) shares increased by 8.5% to $0.63 during Thursday's after-market session. The company's market cap stands at $21.4 million. AN2 Therapeutics (NASDAQ:ANTX) shares increased by 6.76% to $3.47. The company's market cap stands at $103.3 million. GRI Bio (NASDAQ:GRI) stock increased by 6.65% to $0.54. NuCana (NASDAQ:NCNA) shares rose 5.92% to $0.25. The market value of their outstanding shares is at $13.4 million. Stoke Therapeutics (NASDAQ:STOK) shares increased by 5.42% to $12.83. The company's market cap stands at $594.0 million. Candel Therapeutics (NASDAQ:CADL) stock moved upwards by 4.99% to $6.72. The market value of their outstanding shares is at $197
- PRAcorda Therapeutics Announces Nasdaq Delisting NotificationAcorda Therapeutics, Inc. (NASDAQ:ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announcement that it has reached an agreement with Merz Therapeutics to acquire substantially all of the assets of the Company. In connection with that announcement, Acorda and certain of its affiliates filed voluntary petitions to commence Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of New York. Nasdaq commenced proceedings to delist the Company's common stock, based on th
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Aesthetic Medical Intl (NASDAQ:AIH) shares rose 14.0% to $0.52 during Wednesday's after-market session. The company's market cap stands at $24.9 million. Kineta (NASDAQ:KA) shares rose 8.46% to $0.58. The company's market cap stands at $6.3 million. Simulations Plus (NASDAQ:SLP) shares increased by 6.74% to $40.99. The market value of their outstanding shares is at $818.4 million. As per the news, the Q2 earnings report came out today. Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 6.66% to $1.44. The company's market cap stands at $54.9 million. Eiger BioPharmaceuticals (NASDAQ:EIGR) shares increased by 6.66% to $1.76. The market value of their outstanding shares is
- NEWSWhy Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of Ulta Beauty, Inc. (NASDAQ:ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers ARCA biopharma, Inc. (NASDAQ:ABIO) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement. Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences. Next Technology Holding Inc. (NASDAQ:NXTT) rose 57.4% to $6.42. Vanda Ph
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers ARCA biopharma (NASDAQ:ABIO) shares moved upwards by 84.8% to $3.16 during Wednesday's regular session. The market value of their outstanding shares is at $45.8 million. Kintara Therapeutics (NASDAQ:KTRA) stock moved upwards by 71.81% to $0.17. The market value of their outstanding shares is at $6.7 million. Vanda Pharma (NASDAQ:VNDA) shares rose 39.38% to $5.45. The market value of their outstanding shares is at $313.5 million. Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 29.67% to $0.11. The company's market cap stands at $10.5 million. Barinthus Biotherapeutics (NASDAQ:BRNS) shares moved upwards by 27.0% to $3.01. The company's market cap stands at $117.1 million.
- NEWSWhy Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketShares of Cal-Maine Foods, Inc. (NASDAQ:CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from Benzinga Pro. Cal-Maine Foods shares jumped 8.3% to $63.80 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers LAMF Global Ventures Corp. I (NASDAQ:LGVC) rose 148.9% to $26.79 in pre-market trading. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd. Aesthetic Medical International Holdings
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers ARCA biopharma (NASDAQ:ABIO) stock moved upwards by 124.6% to $3.84 during Wednesday's pre-market session. The market value of their outstanding shares is at $55.6 million. Kintara Therapeutics (NASDAQ:KTRA) shares increased by 99.2% to $0.2. The market value of their outstanding shares is at $7.8 million. Aesthetic Medical Intl (NASDAQ:AIH) stock rose 53.03% to $0.52. The market value of their outstanding shares is at $24.7 million. OneMedNet (NASDAQ:ONMD) shares increased by 39.18% to $1.1. The company's market cap stands at $35.4 million. Helius Medical Tech (NASDAQ:HSDT) shares moved upwards by 36.39% to $7.72. The company's market cap stands at $6.8 million. The company's,
- NEWS12 Health Care Stocks Moving In Tuesday's After-Market SessionGainers OneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday's after-market session. The market value of their outstanding shares is at $44.8 million. Aesthetic Medical Intl (NASDAQ:AIH) shares rose 43.48% to $0.49. The market value of their outstanding shares is at $23.1 million. Sight Sciences (NASDAQ:SGHT) shares rose 20.77% to $6.57. The market value of their outstanding shares is at $325.5 million. Inspire Veterinary (NASDAQ:IVP) stock increased by 16.59% to $0.05. The market value of their outstanding shares is at $1.7 million. GlycoMimetics (NASDAQ:GLYC) stock rose 6.41% to $3.15. The market value of their outstanding shares is at $203.0 million. As per t
- NEWSNasdaq Down Over 1%; VivoPower International Shares Spike HigherU.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday. The Dow traded down 1.07% to 39,142.53 while the NASDAQ fell 1.14% to 16,209.12. The S&P 500 also fell, dropping, 0.85% to 5,199.28. Check This Out: Wynn Resorts, Hilton Worldwide And An Energy Stock On CNBC's 'Final Trades' Leading and Lagging Sectors Energy shares jumped by 0.6% on Tuesday. In trading on Tuesday, health care shares fell by 2%. Top Headline The number of job openings rose by 8,000 from the prior month to 8.756 million in February compared to market estimates of 8.75 million. Equities Trading UP VivoPower International PLC (NASDAQ:VVPR) shares
ACOR FAQ
6 questionsWhat does Acorda Therapeutics Inc. do?
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Selincro for the treatment of alcohol dependence; and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for...Where does ACOR stock trade?
Acorda Therapeutics Inc. (ACOR) is listed on NASDAQ.What sector and industry is ACOR in?
Acorda Therapeutics Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Acorda Therapeutics Inc. go public?
Acorda Therapeutics Inc. (ACOR) completed its IPO in 2006.What companies are similar to ACOR?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare ACOR side-by-side with any of them on Quantisnow.How can I track ACOR on Quantisnow?
Quantisnow aggregates Acorda Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ACOR to receive live email and push alerts on every new disclosure.